News

These agreements include a grant by Genentech to Amgen of a license for multiple antibodies relating in part to methods of producing immunoglobulins. Financial details of the license

This is the first time the agency has approved a new oncology product for two indications simultaneously. Sutent, which received a priority review and was approved in less

The third and final planned interim safety analysis was conducted after the first 240 patients were treated in the trial. The data safety monitoring committee (DMC) is a

The successful outcome of this trial would serve as one of two pivotal trials required for a new drug application, which the company hopes to file with the

The novel anticancer activity of these analogs, developed by scientists at MD Anderson, relates to their ability to selectively degrade key proteins that are involved in tumor cell

AeroLef is a proprietary formulation of free and liposome-encapsulated nebulized fentanyl, which permits delivery through the lung. The product provides personalized, patient controlled analgesia to address the unpredictable

Under the expanded agreement Inbio will assume greater day-to-day operational responsibility and majority ownership of CombiMatrix Corporation’s Japanese sales and distribution subsidiary, CombiMatrix KK. Inbio has obtained 67%

The contraceptive gel containing 6% cellulose sulfate is also being developed to prevent sexually transmitted infections including HIV, gonorrhea, and chlamydia infections. Previous clinical safety studies have shown

Profits for the year were $10.4 billion, an increase of 22.4% as compared with 2004, whilst sales for the fourth quarter of $12.6 billion represented a decline of